Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran

• Published in: Journal of orthopaedic surgery and research 2021-03, Vol.16 (1), p.199-199, Article 199
• Main Authors: Tahmasebi, Mohammad Naghi, Vaziri, Arash Sharafat, Vosoughi, Fardis, Tahami, Mohamad, Khalilizad, Majid, Rabie, Hamid
• Format: Article
• Language: English
• Subjects: Age; Analysis; Antibiotic therapy; Antibiotics; Developing countries; Erythema; Health aspects; Implants, Artificial; Infection; Infections; Joint replacement surgery; Joint surgery; LDCs; Medical research; Medicine, Experimental; Orthopedics; Pain; Patients; Polyethylene; Powders; Prevention; Prostheses; Prosthesis; Prosthetic infection; Software; Superficial wound infection; Surgeons; Surgery; Total knee arthroplasty; Tranexamic acid; Vancomycin
• ISSN: 1749-799X; 1749-799X
• DOI: 10.1186/s13018-021-02344-2

Utilizing intrawound vancomycin powder in TKA surgery has yielded rather contrasting results in the current literature. Furthermore, CDC criteria, although effective in general, are not specifically designed for post-TKA infections. Here, we present a 7-year experience of vancomycin use in primary TKA in a high-volume tertiary knee center in Iran. Also, new criteria are proposed to detect suspected superficial post-TKA infections. This is a retrospective analysis of primary total knee arthroplasties performed in a tertiary knee center, from March 2007 to December 2018, by a single senior knee surgeon. All patients with follow-up periods of less than 1 year were excluded from the study. Since March 2011, all patients received vancomycin (powder, 1 g) before water-tight closure of the joint capsule. A comparison was made between this group and historical control subjects (operated from March 2007 to March 2011). Altogether, 2024 patients were included in the study. The vancomycin and the control groups included 1710 and 314 cases respectively. Patients were mostly women (male to female ratio, 1 to 4), with a mean age of 65.20 (SD = 10.83) years. In the vancomycin group, the rate of suspected SII (1.87%) and PJI (0.41%) was significantly lower than the control group (P = 0.002). Our experience shows that application of local vancomycin during TKA surgery could be a reasonable infection prevention measure, although prospective randomized studies are required to evaluate its efficacy.